Home
C1 Uses
C1 Technology
Investors
Media Center
About
Careers
Contact Us
Vaccines
Antibodies
BIOSIMILARS
BIOBETTERS
BIOPHARMACEUTICALS
ENZYME THERAPIES
ANIMAL HEALTH
BIOTHERAPEUTIC MANUFACTURING
ENZYME CATALYSTS
C1 Expression System
Licensees / Collaborators
Manufacturing
R&D Facilities
The White Strain™
Analysts
Corporate Profile
Corporate Governance
Filings and Disclosures
Financial Statements
Proxy Statements
Stock Information
The Dyadic Story
Executives & Advisors
Careers
Contact Us
Events
Press Releases
Articles
Presentations
Scientific Publications
Video Gallery
Dyadic
®
Reinventing Biologic Vaccine and Drug Development & Production
The Science Behind Dyadic’s C1
Gene Expression Platform
Biopharmaceuticals
As the aging population grows there is a critical need to bring biologic vaccines and drugs to market faster, with improved performance, in greater volumes to improve access and reduce costs to patients and the healthcare system.
Find out more >
C1 Technology Platform
The industrially proven C1 Expression System has the potential to bring novel biologic drugs such as vaccines and antibodies to market faster, in greater volumes and at lower cost to patients and the healthcare system.
Find out more >
Research & Development
The C1 technology platform is being used by leading global companies which includes BASF, DuPont and others.
Find out more >
Partnering & Licensing
Dyadic is seeking partnerships to sub-license, or partner its C1 platform technology in the vaccine, antibody and biosimilar industries.
Find out more >
Manufacturing
We have industrial scale manufacturing expertise at up to 500,000 liter scale. Commercial products have been produced utilizing the C1 platform technology at industrial scale in 5 countries over 17 years.
Find out more >
Biopharmaceuticals
As the aging population grows there is a critical need to bring biologic vaccines and drugs to market faster, with improved performance, in greater volumes to improve access and reduce costs to patients and the healthcare system.
Find out more >
C1 Technology Platform
The industrially proven C1 Expression System has the potential to bring novel biologic drugs such as vaccines and antibodies to market faster, in greater volumes and at lower cost to patients and the healthcare system.
Find out more >
Research & Development
The C1 technology platform is being used by leading global companies which includes BASF, DuPont and others.
Find out more >
Partnering & Licensing
Dyadic is seeking partnerships to sub-license, or partner its C1 platform technology in the vaccine, antibody and biosimilar industries.
Find out more >
Manufacturing
We have industrial scale manufacturing expertise at up to 500,000 liter scale. Commercial products have been produced utilizing the C1 platform technology at industrial scale in 5 countries over 17 years.
Find out more >
UPCOMING EVENTS
HC Wainwright Global Investment Conference
May 23-26, 2022 - Miami, FL
Read More
VIEW ALL
Dyadic
Investor Center
LEARN MORE
Twitter
Linkedin
Facebook
Media Center
Contact Us
Dyadic
Press Releases
LEARN MORE